tirzepatide vs semaglutide efficacy side effects caused roughly half as many patients to stop treatment because of gastrointestinal as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide What is the Difference Between

Data from a large retrospective cohort study to be presented at the 2026 American Society of Clinical Oncology (ASCO) Breakthrough Meeting showed that GLP-1 receptor agonist (GLP-1 RA) use was significantly associated with lower colorectal cancer incidence among patients with inflammatory bowel disease (IBD), including those with comorbid type 2 diabetes (T2D)

All domestic orders receive free shipping regardless of price

A study utilizing a national database found that individuals treated with GLP-1 receptor agonists had a significantly lower risk of developing glaucoma compared to those who were not on these medications

Preliminary studies in animals are indicating that adding copper may actually be protective

IcoSema versus separate administration of semaglutide) was included as a covariate on F and k A

Many effective medications carry serious risks